Bellevue Group AG
CIK: 0001674546Latest portfolio: $5.3B · Q4 2025
Holdings
176
Total Value
$5.3B
New Positions
37
Closed Positions
9
Top Holdings
View All 176 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 5,005,719 | $398.7M | 7.56% | -568,119 | |
| 2 | ARGXARGENX SE | 461,854 | $388.4M | 7.36% | -84,474 | |
| 3 | ISIIONIS PHARMACEUTICALS INC | 4,802,199 | $379.9M | 7.20% | -1,442,252 | |
| 4 | VRTXVERTEX PHARMACEUTICALS INC | 681,120 | $308.8M | 5.85% | +175K | |
| 5 | NBIXNEUROCRINE BIOSCIENCES INC | 1,703,304 | $241.6M | 4.58% | -59,801 | |
| 6 | RNAAVIDITY BIOSCIENCES INC | 2,630,969 | $189.8M | 3.60% | +478K | |
| 7 | ISRGINTUITIVE SURGICAL INC | 322,028 | $182.4M | 3.46% | -26,598 | |
| 8 | SRRKSCHOLAR ROCK HLDG CORP | 4,056,592 | $178.7M | 3.39% | +812K | |
| 9 | ALNYALNYLAM PHARMACEUTICALS INC | 445,903 | $177.3M | 3.36% | -621 | |
| 10 | ABTABBOTT LABS | 1,316,915 | $165.0M | 3.13% | -161,648 | |
| 11 | AM6AMICUS THERAPEUTICS INC | 10,735,195 | $152.9M | 2.90% | NEW | |
| 12 | BSXBOSTON SCIENTIFIC CORP | 1,559,606 | $148.7M | 2.82% | -100,243 | |
| 13 | VRDNVIRIDIAN THERAPEUTICS INC | 4,358,527 | $135.6M | 2.57% | NEW | |
| 14 | SYKSTRYKER CORPORATION | 360,577 | $126.7M | 2.40% | -90,519 | |
| 15 | NUVLNUVALENT INC | 1,037,468 | $104.4M | 1.98% | NEW | |
| 16 | KRYSKRYSTAL BIOTECH INC | 410,323 | $101.2M | 1.92% | +409K | |
| 17 | TCE2CELLDEX THERAPEUTICS INC NEW | 3,617,669 | $98.3M | 1.86% | +60K | |
| 18 | IMCRIMMUNOCORE HLDGS PLC | 2,796,803 | $97.1M | 1.84% | — | |
| 19 | EWEDWARDS LIFESCIENCES CORP | 1,043,096 | $88.9M | 1.69% | +146K | |
| 20 | VERAVERA THERAPEUTICS INC | 1,698,152 | $86.0M | 1.63% | NEW | |
| 21 | MDTMEDTRONIC PLC | 766,592 | $73.6M | 1.40% | +7K | |
| 22 | RLAYRELAY THERAPEUTICS INC | 8,345,364 | $70.6M | 1.34% | -246 | |
| 23 | IDXXIDEXX LABS INC | 94,539 | $64.0M | 1.21% | +18K | |
| 24 | UNHUNITEDHEALTH GROUP INC | 175,169 | $57.8M | 1.10% | +5K | |
| 25 | DC4DEXCOM INC | 847,405 | $56.2M | 1.07% | +61K |
Quarterly Changes
New Positions
Increased Positions
Sector Breakdown
HealthcareNaN% ($InfinityT)
Unknown0.0% ($3.799011528699826e+44T)
Technology0.0% ($7.91690273362862e+25T)
Financial Services0.0% ($21131329627566.5T)
Consumer Cyclical0.0% ($817688465.3T)
Communication Services0.0% ($646.5M)
Consumer Defensive0.0% ($558K)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | $5.3B | 213 |
| Q3 2025 | Nov 14, 2025 | $4.8T | 186 |
| Q2 2025 | Aug 14, 2025 | $4.5T | 175 |
| Q1 2025 | May 14, 2025 | $4.5T | 177 |
| Q4 2024 | Feb 14, 2025 | $5.2T | 193 |
| Q3 2024 | Nov 14, 2024 | $6172.6T | 196 |
| Q2 2024 | Aug 14, 2024 | $6154.3T | 204 |
| Q1 2024 | May 15, 2024 | $6556.9T | 208 |
| Q4 2023 | Feb 14, 2024 | $6537.5T | 202 |
| Q3 2023 | Nov 14, 2023 | $6206.9T | 196 |
| Q2 2023 | Aug 14, 2023 | $7010.4T | 198 |
| Q1 2023 | May 15, 2023 | $6891.2T | 202 |
| Q4 2022 | Feb 14, 2023 | $7534.6T | 215 |
| Q3 2022 | Nov 14, 2022 | $7.0T | 217 |
| Q2 2022 | Aug 11, 2022 | $7.1T | 214 |
| Q1 2022 | May 13, 2022 | $8.6T | 220 |
| Q4 2021 | Feb 10, 2022 | $9.7T | 235 |
| Q3 2021 | Nov 12, 2021 | $9.9T | 265 |
| Q2 2021 | Aug 12, 2021 | $10.2T | 262 |
| Q1 2021 | May 12, 2021 | $9.5T | 260 |
| Q4 2020 | Feb 16, 2021 | $8.7T | 266 |
| Q3 2020 | Nov 16, 2020 | $7.2T | 261 |
| Q2 2020 | Aug 13, 2020 | $7.1T | 235 |
| Q1 2020 | May 14, 2020 | $5.2T | 239 |
| Q4 2019 | Feb 14, 2020 | $6.3T | 239 |
| Q3 2019 | Nov 14, 2019 | $5.4T | 236 |
| Q2 2019 | Aug 14, 2019 | $5.9T | 219 |
| Q1 2019 | May 15, 2019 | $1.8T | 138 |
| Q4 2018 | Feb 12, 2019 | $1.5T | 138 |
| Q3 2018 | Nov 13, 2018 | $1.6T | 138 |
| Q2 2018 | Aug 7, 2018 | $1.2T | 138 |
| Q1 2018 | May 9, 2018 | $1.0T | 124 |
| Q4 2017 | Feb 14, 2018 | $957.2B | 134 |
| Q3 2017 | Nov 13, 2017 | $956.1B | 131 |
| Q2 2017 | Aug 14, 2017 | $845.7B | 132 |
| Q1 2017 | May 11, 2017 | $750.4B | 132 |
| Q4 2016 | Feb 10, 2017 | $488.3B | 122 |
| Q3 2016 | Nov 10, 2016 | $553.5B | 121 |
| Q2 2016 | Aug 12, 2016 | $531.5B | 124 |
| Q1 2016 | May 16, 2016 | $551.1B | 130 |
Fund Information
Bellevue Group AG is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $5.3B across 176 holdings. The largest position is REVOLUTION MEDICINES INC (RVMD), representing 7.6% of the portfolio. Compared to the previous quarter, the fund opened 37 new positions and closed 9 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.